top of page

Designed for Endometriosis.
Built for Longitudinal Insight.

Endometriosis is not just a gynecologic condition—it’s a chronic, systemic disease that affects hormonal signaling, inflammation, metabolism, and long-term cardiovascular health.

 

EndoCare™ was designed specifically for people diagnosed with or highly suspicious of endometriosis, with a focus on trend tracking over time, not one-time lab snapshots.

Because when baseline risk is already elevated, the goal isn’t just normal.
 

The goal is optimal.

Learn what we test and why...

A Panel Built for Long-Term Endometriosis Care

Every marker in the EndoCare™ panel was selected to reflect the interconnected systems impacted by endometriosis—and to provide data you and your clinician can use to make informed, proactive decisions.

All testing is processed through a CLIA-certified laboratory, with results presented in a clear, easy-to-read format designed to support clinical conversations.

Reference Range Disclaimer
Reference ranges are provided to support interpretation in the context of endometriosis and reflect national laboratory standards and condition-specific guidance. These ranges are not intended to replace clinical judgment. Healthcare providers may interpret results differently based on an individual’s medical history and clinical context.

Want to explore the science behind these markers?

Visit our Science page to learn how each marker fits into a broader biological framework and why longitudinal tracking matters.

Hormones & Hormone Bioavailability

Markers tested: Estradiol (E2), SHBG, Total Testosterone, Free Testosterone (Calculated), DHEA-Sulfate

Endometriosis is hormone-responsive—but symptoms are often driven by imbalance and bioavailability, not just hormone levels.

This group of tests helps assess:

  • Estrogen activity and trends

  • How much testosterone is actually available to tissues

  • Adrenal hormone contribution

  • Hormone signaling patterns that may influence pain, fatigue, mood, and flares

 

Why it matters:
Hormone-related symptoms can occur even when individual values fall within reference ranges. Tracking how these markers change together over time provides deeper insight.

Stress Physiology & Adrenal Health

Markers tested: Cortisol, DHEA-Sulfate

Living with endometriosis places ongoing demand on the body’s stress response system.

These markers help assess:

  • Chronic stress signaling

  • Adrenal reserve and resilience

  • Patterns that may contribute to fatigue, sleep disruption, and symptom escalation

 

Why it matters:
Chronic stress can worsen inflammation, disrupt hormones, and affect metabolic health—especially in long-standing inflammatory conditions.

Inflammation & Immune Activity

Example markers tested: Hs-CRP (Cardiac), Albumin, Cortisol, plus others

These markers help evaluate:

  • Ongoing inflammatory burden

  • Context for immune and nutritional status

  • Trends that may precede symptom flares or long-term risk

 

Why it matters:
For people with endometriosis, consistently low and stable inflammation is often more meaningful than simply being “within range.”

Cardiovascular & Metabolic Health

Markers tested: Lipid Panel, Apolipoprotein B, Hemoglobin A1c

Research shows that people with endometriosis carry an increased lifetime risk of cardiometabolic disease.

This group helps assess:

  • Cholesterol and triglyceride patterns

  • Atherogenic particle burden (ApoB)

  • Long-term glucose regulation and insulin resistance risk

 

Why it matters:
Early metabolic and cardiovascular changes often develop silently. Trend-based monitoring supports prevention—before disease progression.

Micronutrients & Iron Storage

Markers tested: Vitamin D, Ferritin

These nutrients are frequently suboptimal in people with endometriosis and play a role in:

  • Pain perception

  • Energy and fatigue

  • Immune balance

  • Bone and muscle health

 

Why it matters:
“Low-normal” levels may still be insufficient when managing chronic inflammation.

Why Longitudinal
Testing Matters

EndoCare™ is designed to be used twice per year, allowing you and your clinician to:

  • Establish a personal baseline

  • Identify subtle changes early

  • Track how interventions are working

  • Reduce flare severity and frequency

  • Support long-term heart and metabolic health.
     

This is not reactive testing.

It’s informed, proactive care.

The EndoCare™ Difference

  • Endometriosis changes your baseline risk.

  • EndoCare helps you see what’s changing—before it becomes a problem.

 

EndoCare™ empowers patients with meaningful data and supports clear, informed patient–clinician dialogue through trend-based insight.

COMING SOON

Get in Touch

Please reach out to our Scientific Advisor for any questions you may have about our test panel. 

bottom of page